Ecopa 2018 Symposium

Noushin Dianat, 21 October 2018 | Past event

This year’s European Consensus-Platform for Alternatives (ECOPA) Symposium will be held from 5th to 6th November in Paris.

The French platform for the development of alternative methods in animal testing (Francopa) has organized the 2018 symposium with exciting talks around:

“How new experimental tools in life sciences challenge the 3Rs vision?”

Cyprio is proud to be part of this event by presenting it’s innovative human Liver Pearls as physiologically relevant alternatives to animal models:

HepatoPearls: New generation of liver-mimicking spheroids
5th November 2018 – 1:50 pm – 2:10 pm

Looking forward to seeing you soon in Paris!

ALTERTOX ACADEMY HANDS-ON TRAINING

Noushin Dianat, 30 March 2018 | Past event

Altertox Academy : UPDATE IN IN VITRO LIVER SYSTEM: CELLS TO ORGANOID

www.academy.altertox.be

 

Cyprio is proud to participate for the second consecutive year in Altertox Academy Hands-on trainings.

We are excited to present for the very first time our new liver model the “RGPearl” generated from differentiated HepaRG cells in this upcoming edition. Participants of the workshop will have the opportunity to work with this innovative liver 3D cellular model as well as with our famous HepatoPearls. Cyprio team will explain interesting features about these novel products and their application in DMPK and toxicity.

Do you want to know more about our innovative 3D liver models? Don’t miss this unique chance. Come and work with them and learn all about the liver Pearls universe!

Postdoctoral Position

Matthieu Devaux, 5 February 2018 | Job offer

Hepatocyte and Pancreatic cell 3D models development and validation for drug screening and therapeutics

 

Who is Cyprio?

Created in 2017, Cyprio is founded on ten years of research that makes Cyprio the
holder of a unique technology “BioPearl” for fabrication of cell spheroids as
predictive vivo-mimicking 3D cellular models. Our first product “HepatoPearl” has
been validated as an improved in vitro liver model for many applications, from
drug-drug interaction screening, chronic toxicity and metabolism of low clearance
compounds to disease modelling.

Cyprio is further developing new products to definitively change liver cell culture
biology approach towards more complex yet more relevant and robust, easier to
handle and HTS compatible spheroid based 3D models.

 

What we look for?

As a fast growing company, we are recruiting an outstanding Postdoctoral
Research Associate for Hepatocyte and Pancreatic cell 3D models development
and validation for drug screening and therapeutics.

The position involves working in a multidisciplinary team of experienced scientists
to outrank and replace existing 3D and traditional 2D cell culture models. Joining
means entering our highly challenging fields of interest: disease modelling, drug
discovery and development, organ regeneration and therapeutic alternatives.

 

Who we look for?

We are looking for a star cell culture biologist with a PhD in life sciences and over
3 years experience in the field of hepatology (disease modelling, toxicity,
regeneration, transplantation …). Post-doc experience is not mandatory. Expertise
in human pluripotent stem cell and pancreatic cell culture would be highly
appreciated.

Excellent publication record and strong scientific project and grant application
writing skills are highly expected.

As a young high-value company, we look for a highly motivated and proactive
collaborator featuring culture of excellence and team play, proven analytical and
creative thinking, sharp problem-solving capabilities.

As a company targeting the world, French and English are compulsory.

This is your opportunity to use your skills in liver, pancreatic and human pluripotent
stem cell culture at the forefront of a revolution in 3D cell modelling using a cutting
edge spheroid generation technology in a young fast-growing high-value
company.

You can send your CV and cover letter tracing your professional record and two
recommendation letters to contact@cyprio.fr.

Society of Toxicology (SOT) 57th annual meeting and ToxExpo

 , 5 January 2018 | Past event

Cyprio will attend the SOT 2018 annual meeting where attendees can learn more about the company’s technology, products and achievements thus far.

Cyprio is looking forward to presenting their exciting, patented, HepatoPearl technology for high throughput drug screening. Please don’t hesitate to visit our booth, number 1420.

We will also present two posters about two different applications of our HepatoPearls at SOT:

  • Poster board number P451: Novel Liver Spheroids for High-Throughput Drug-Drug Interaction Screening by Next-Generation-Sequencing
  • Poster board number P785: HepatoPearl: A Novel Tool for In Vitro Predictive Hepatotoxicity Screening

Looking forward to seeing you there!

Society for Laboratory Automation and Screening (SLAS) International conference

 , 4 January 2018 | Past event

This year SLAS international conference will be held in San Diego, California and Cyprio has signed on to give a talk about their patented HepatoPearl technology entitled “Automation and high throughput technologies”. Cyprio’s session will be on February 5th, 2018 at 12-12:30pm. As always, guests are all invited to come and learn more about the HepatoPearl model and the company itself.

www.slas2018.org

3D Cell Model Congress

 , 3 January 2018 | Past event

Cyprio will present new applications of their HepatoPearl drug screening technology on January 25, 2018 at 16:30 in Berlin. You are all invited to learn more about Cyprio’s exciting new developments.

3dcellmodelscongress.com/events/3d-cell-models-congress

Cyprio Webinar

 , 2 January 2018 | Past event

Cyprio Webinar: HepatoPearls, a new liver-mimicking 3D cellular model for drug screening

Speaker: Dr Noushin Dianat, CEO of Cyprio

We are pleased to announce that Cyprio will host its very first webinar to present BioPearl technology and the innovative Liver 3D cellular model, HepatoPearl.

Do you want to know more about HepatoPearls and their application in drug screening? Cyprio will hold a webinar on Friday 2nd February 2018 at 3pm Paris local time (UTC +1). With a WebEx account, you are free to subscribe to the event link below. If you don’t have a WebEx account, you just need to subscribe to our Newsletter on “contact” page and the link to the webinar will be communicated to you automatically.

https://meetings.webex.com/collabs/meetings/view?uuid=M4TC3UUUY9VI0DVZ9NGXBJ5OIU-1AYW5&ucs=email

Haut de page